Welcome to the team, Jon! CellCentric continuing to build leadership and expertise, as we scale up production of inobrodib, advancing to towards pivotal clinical studies. https://lnkd.in/eGGvsUei Inobrodib: first-in-class oral inhibitor of the bromodomain of p300/CBP. Treating specific cancers, notably multiple myeloma. #multiplemyeloma
Thanks Will. Great to be joining at this exciting time!
Jonathan Cummins you're joining a great company
Congratulations on your new role. Hope all’s well
Congratulations Jon!!!!
Fantastic news 😀
Congratulations Jon.
Well done and well deserved, and best of luck Jon
Congratulations to CellCentric great addition to the team, let’s catch up soon Jon!
Congratulations John. Wishing you the very best in the new role.
VP, Head of medicinal Chemistry Aqilion CEO BioZet AB
11moCongrats Jon and congrats to Cellventric for catching one of the best!